Similarities and differences in interactions of thyroid stimulating and blocking autoantibodies with the TSH receptor

Journal of Molecular Endocrinology

Volumn 49, Issue 2, 2012, Pages 137-151

  Miguel, Ricardo Núñez ^a   Sanders, Jane ^a   Sanders, Paul ^a   Young, Stuart ^a   Clark, Jill ^a   Kabelis, Katarzyna ^a   Wilmot, Jane ^a   Evans, Michele ^a   Roberts, Emma ^a   Hu, Xiaoling ^a   Furmaniak, Jadwiga ^a   Smith, Bernard Rees ^a  

^a RSR LTD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; THYROTROPIN BETA SUBUNIT; THYROTROPIN RECEPTOR; THYROTROPIN RECEPTOR ANTIBODY;

ALPHA CHAIN; ANIMAL EXPERIMENT; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CRYSTAL STRUCTURE; HEAVY CHAIN; LIGHT CHAIN; MOLECULAR INTERACTION; MOUSE; MUTATION; NONHUMAN; PRIORITY JOURNAL; WILD TYPE;

ANIMALS; ANTIBODIES, MONOCLONAL; AUTOANTIBODIES; BINDING SITES, ANTIBODY; CHO CELLS; CRICETINAE; CRYSTALLOGRAPHY, X-RAY; CYCLIC AMP; HUMANS; MODELS, MOLECULAR; MUTATION; PROTEIN CONFORMATION; RECEPTORS, THYROTROPIN;

EID: 84866427649     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-12-0040     Document Type: Article

References (55)

1. Bolton J, Sanders J, Oda Y, Chapman C, Konno R, Furmaniak J & Rees Smith B 1999 Measurement of thyroid-stimulating hormone receptor autoantibodies by ELISA. Clinical Chemistry 45 2285-2287.
2. Chen C-R, McLachlan SM & Rapoport B 2010 Thyrotropin (TSH) receptor residue E251 in the extracellular leucine-rich repeat domain is critical for linking TSH binding to receptor activation. Endocrinology 151 1940-1947. (doi:10.1210/en.2009-1430)
3. Collaborative Computational project, number 4 1994 The CCP4 Suite: Programmes for protein crystallography. Acta Crystallographica D50 760-763. (doi:10.1107/S0907444994003112)
4. Costagliola S, Bonomi M, Morgenthaler NG, Van Durme J, Panneels V, Refetoff S & Vassart G 2004 Delineation of the discontinuousconformational epitope of a monoclonal antibody displaying full in vitro and in vivo thyrotropin activity. Molecular Endocrinology 18 3020-3034. (doi:10.1210/me.2004-0231)
5. DeLano WL 2002 The PyMOL Molecular Graphics System. San Carlos, CA, USA: DeLano Scientific (http://sourceforge.net/projects/pymol).
6. Dupakuntla M & Mahale SD 2010 Accessibility of the extracellular loops of follicle stimulating hormone receptor and their role in hormone-receptor interaction. Molecular and Cellular Endocrinology 315 131-137. (doi:10.1016/j.mce.2009.10.002)
7. Emsley P, Lohkamp B, Scott W & Cowtan K 2010 Features and developments of COOT. Acta Crystallographica D66 486-501. (doi: 10.1107/S0907444910007493)
8. Evans M, Sanders J, Tagami T, Sanders P, Young S, Roberts E, Wilmot J, Hu X, Kabelis K, Clark J et al. 2010 Monoclonal autoantibodies to the TSH receptor, one with stimulating activity and one with blocking activity, obtained from the same blood sample. Clinical Endocrinology 73 404-412. (doi:10.1111/j.1365-2265.2010.03831.x)
9. Fan QR & Hendrickson WA 2005 Structure of human follicle stimulating hormone in complex with its receptor. Nature 433 269-277. (doi:10.1038/nature03206)
10. Gasteiger E, Hoogland C, Gattiker A, Duvaud S, Wilkins MR, Appel RD & Bairoch A 2005 Protein identification and analysis tools on the ExPASy server. In The Proteomics Protocols Handbook, pp 581-582. Ed John M Walker. New Jersey: Humana Press.
11. Hamidi S, Chen CR, Mizutori-Sasai Y, McLachlan SM & Rapoport B 2011 Relationship between thyrotropin receptor hinge region proteolytic posttranslational modification and receptor physiological function. Molecular Endocrinology 25 184-194. (doi:10.1210/me. 2010-0401)
12. Jones S & Thornton JM 1996 Principles of protein-protein interactions. PNAS 93 13-20. (doi:10.1073/pnas.93.1.13)
13. Kabat E, Perry H, Wu T, Gottesman K & Foeller C 1991 Sequences of Proteins of Immunological Interest, 5th edn. Bethesda, MD: US Public Health Service.
14. Kim WB, Cho BY, Park HY, Lee HK, Kohn LD, Tahara K & Koh CS 1996 Epitopes for thyroid-stimulating antibodies in Graves' sera: a possible link of heterogeneity to differences in response to antithyroid drug treatment. Journal of Clinical Endocrinology and Metabolism 81 1758-1767. (doi:10.1210/jc.81.5.1758)
15. Kim WB, Chung HK, Lee HK, Kohn LD, Tahara K & Cho BY 1997 Changes in epitopes for thyroid-stimulating antibodies in Graves' disease sera during treatment of hyperthyroidism: therapeutic implications. Journal of Clinical Endocrinology and Metabolism 82 1953-1959. (doi:10.1210/jc.82.6.1953)
16. Kleinau G & Krause G 2009 Thyrotropin and homologous glycoprotein hormone receptors: structural and functional aspects of extracellular signaling mechanisms. Endocrine Reviews 30 133-151. (doi:10.1210/er.2008-0044)
17. Kleinau G, Jaeschke H, Mueller S, Raaka BM, Neumann S, Paschke R & Krause G 2008 Evidence for cooperative signal triggering at the extracellular loops of the TSH receptor. FASEB Journal 22 2798-2808. (doi:10.1096/fj.07-104711)
18. Kosugi S, Ban T & Kohn LD 1993 Identification of thyroid-stimulating antibody-specific interaction sites in the N-terminal region of the thyrotropin receptor. Molecular Endocrinology 7 114-130. (doi:10.1210/me.7.1.114)
19. Kung AW, Lau KS & Kohn LD 2001 Epitope mapping of TSH receptor-blocking antibodies in Graves' disease that appear during pregnancy. Journal of Clinical Endocrinology and Metabolism 86 3647-3653. (doi:10.1210/jc.86.8.3647)
20. Kyte J & Doolittle RF 1982 A simple method for displaying the hydropathic character of a protein. Journal of Molecular Biology 157 105-132. (doi:10.1016/0022-2836(82)90515-0)
21. Laskowski RA, MacArthur MW, Moss DS & Thornton JM 1993 PROCHECK-a program to check the stereochemical quality of protein structures. Journal of Applied Crystallography 26 283-291. (doi:10.1107/S0021889892009944)
22. Loos U, Franz C, Minich WB & Büsselmann I 2007 Direct assay of TSH receptor autoantibodies causing Graves' disease correlates with the clinical diagnosis closer than assays based on TSH displacement. Hormone Research 68 63. (doi: 10.1159/000107670)
23. McLachlan SM & Rapoport B 1996 Monoclonal human autoantibodies to the TSH receptor-the holy grail and why are we looking for it? Journal of Clinical Endocrinology and Metabolism 81 3152-3154. (doi:10.1210/jc.81.9.3152)
24. Minich WB & Loos U 2000 Detection of functionally different types of pathological autoantibodies against thyrotropin receptor in Graves' patients sera by luminescent immunoprecipitation analysis. Experimental and Clinical Endocrinology & Diabetes 108 110-119. (doi:10.1055/s-2000-5804)
25. Minich WB, Lenzner C, Bergmann A & Morgenthaler NG 2004 A coated tube assay for the detection of blocking thyrotropin receptor autoantibodies. Journal of Clinical Endocrinology and Metabolism 89 352-356. (doi:10.1210/jc.2003-030823)
26. Mizutori Y, Chen C-R, McLachlan SM & Rapoport B 2008 The thyrotropin receptor hinge region is not simply a scaffold for the leucine-rich domain but contributes to ligand binding and signal transduction. Molecular Endocrinology 22 1171-1182. (doi:10.1210/me.2007-0407)
27. Morgenthaler NG, Minich WB, Willnich M, Bogusch T, Hollidt JM, Weglohner W, Lenzner C & Bergmann A 2003 Affinity purification and diagnostic use of TSH receptor autoantibodies from human serum. Molecular and Cellular Endocrinology 212 73-79. (doi:10.1016/j.mce.2003.09.018)
28. Morgenthaler NG, Ho SC &Minich WB 2007 Stimulating and blocking thyroid stimulating hormone (TSH) receptor autoantibodies from patients with Graves' disease and autoimmune hypothyroidism have very similar concentration, TSH receptor affinity, and binding sites. Journal of Clinical Endocrinology and Metabolism 92 1058-1065. (doi:10.1210/jc.2006-2213)
29. Moyle WR, Xing Y, Lin W, Cao D, Myers RV, Kerrigan JE & Bernard MP 2004 Model of glycoprotein hormone receptor ligand binding and signaling. Journal of Biological Chemistry 279 44442-44459. (doi:10.1074/jbc.M406948200)
30. Mueller S, Kleinau G, Jaeschke H, Paschke R & Krause G 2008 Extended hormone binding site of the human thyroid stimulating hormone receptor: distinctive acidic residues in the hinge region are involved in bovine thyroid stimulating hormone binding and receptor activation. Journal of Biological Chemistry 283 18048-18055. (doi:10.1074/jbc.M800449200)
31. Mueller S, Jaeschke H, Günther R & Paschke R 2009 The hinge region: an important receptor component for GPHR function. Trends in Endocrinology and Metabolism 21 111-122. (doi:10.1016/j.tem.2009. 09.001)
32. Nagayama Y, Wadsworth HL, Russo D, Chazenbalk GD & Rapoport B 1991 Binding domains of stimulatory and inhibitory thyrotropin (TSH) receptor autoantibodies determined with chimeric TSH-lutropin/chorionic gonadotropin receptors. Journal of Clinical Investigation 88 336-340. (doi:10.1172/JCI115297)
33. Núñez Miguel R, Sanders J, Jeffreys J, Depraetere H, Evans M, Richards T, Blundell TL, Rees Smith B & Furmaniak J 2004 Analysis of the thyrotropin receptor-thyrotropin interaction by comparative modeling. Thyroid 14 991-1011. (doi:10.1089/thy. 2004.14.991)
34. Núñez Miguel R, Sanders J, Blundell TL, Rees Smith B & Furmaniak J 2005 Comparative modeling of the thyrotropin receptor. Thyroid 15 746-747. (doi:10.1089/thy.2005.15.746)
35. Núñez Miguel R, Sanders J, Chirgadze DY, Blundell TL, Furmaniak J & Rees Smith B 2008 FSH and TSH binding to their respective receptors-similarities, differences and implications for glycoprotein hormone specificity. Journal of Molecular Endocrinology 41 145-164. (doi:10.1677/JME-08-0040)
36. Núñez Miguel R, Sanders J, Chirgadze DY, Furmaniak J & Rees Smith B 2009 Thyroid stimulating autoantibody M22 mimics TSH in its binding to the TSH receptor leucine rich domain: a comparative structural study of protein-protein interactions. Journal of Molecular Endocrinology 42 381-395. (doi:10.1677/JME-08-0152)
37. Rapoport B, Chazenbalk GD, Jaume JC & McLachlan SM 1998 The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies. Endocrine Reviews 19 673-716. (doi:10.1210/er.19.6.673)
38. Rees Smith B, Sanders J, Evans M, Tagami T & Furmaniak J 2009 TSH receptor-autoantibody interactions. Hormone and Metabolic Research 41 448-455. (doi:10.1055/s-0029-1220913)
39. Sanders J, Oda Y, Roberts S, Kiddie A, Richards T, Bolton J, McGrath V, Walters S, Jaskó lski D, Furmaniak J et al. 1999 The interaction of TSH receptor autoantibodies with 125I-labelled TSH receptor. Journal of Clinical Endocrinology and Metabolism 84 3797-3802. (doi:10.1210/jc.84.10.3797)
40. Sanders J, Jeffreys J, Depraetere H, Richards T, Evans M, Kiddie A, Brereton K, Groenen M, Oda Y, Furmaniak J et al. 2002 Thyroid stimulating monoclonal antibodies. Thyroid 12 1043-1050. (doi:10.1089/105072502321085135)
41. Sanders J, Jeffreys J, Depraetere H, Evans M, Richards T, Kiddie A, Brereton K, Premawardhana LDKE, Chirgadze DY, Núñez Miguel R et al. 2004 Characteristics of a human monoclonal autoantibody to the thyrotropin receptor: sequence structure and function. Thyroid 14 560-570. (doi:10.1089/1050725041692918)
42. Sanders J, Allen F, Jeffreys J, Bolton J, Richards T, Depraetere H, Nakatake N, Evans M, Kiddie A, Premawardhana LDKE et al. 2005 Characteristics of a monoclonal antibody to the thyrotropin receptor that acts as a powerful thyroid-stimulating autoantibody antagonist. Thyroid 15 672-682. (doi:10.1089/thy.2005.15.672)
43. Sanders J, Bolton J, Sanders P, Jeffreys J, Nakatake N, Richards T, Evans M, Kiddie A, Summerhayes S, Roberts E et al. 2006 Effects of TSH receptor mutations on binding and biological activity of monoclonal antibodies and TSH. Thyroid 16 1195-1206. (doi:10.1089/thy.2006.16.1195)
44. Sanders J, Chirgadze DY, Sanders P, Baker S, Sullivan A, Bhardwaja A, Bolton J, Reeve M, Nakatake N, Evans M et al. 2007a Crystal structure of the TSH receptor in complex with a thyroid stimulating autoantibody. Thyroid 17 395-410. (doi:10.1089/thy.2007.0034)
45. Sanders J, Núñez Miguel R, Bolton J, Bhardwaja A, Sanders P, Nakatake N, Evans M, Blundell TL, Furmaniak J & Rees Smith B 2007b Molecular interactions between the TSH receptor and a thyroid stimulating monoclonal autoantibody. Thyroid 17 699-706. (doi:10.1089/thy.2007.0041)
46. Sanders J, Núñez Miguel R, Furmaniak J & Rees Smith B 2010 TSH receptor monoclonal antibodies with agonist, antagonist, and inverse agonist activity. Methods in Enzymology 485 393-420. (doi:10. 1016/B978-0-12-381296-4.00022-1)
47. Sanders P, Young S, Sanders J, Kabelis K, Baker S, Sullivan A, Evans M, Clark J, Wilmot J, HuXet al. 2011 Crystal structure of theTSHreceptor (TSHR) bound to a blocking-type TSHR autoantibody. Journal of Molecular Endocrinology 46 81-99. (doi:10.1530/JME-10-0127)
48. Schwarz-Lauer L, Chazenbalk GD, Mclachlan SM, Ochi Y, Nagayama Y & Rapoport B 2002 Evidence for a simplified view of autoantibody interactions with the thyrotropin receptor. Thyroid 12 115-120. (doi:10.1089/105072502753522347)
49. Stanfield RL, Zemla A, Wilson IA & Rupp B 2006 Antibody elbow angles are influenced by their light chain class. Journal of Molecular Biology 357 1566-1574. (doi:10.1016/j.jmb.2006.01.023)
50. Szkudlinski MW, Teh NG, Grossmann M, Tropea JE & Weintraub BD 1996 Engineering human glycoprotein hormone superactive analogues. Nature Biotechnology 14 1257-1263. (doi:10.1038/nbt1096-1257)
51. Szkudlinski MW, Fremont V, Ronin C & Weintraub BD 2002 Thyroidstimulating hormone and thyroid-stimulating hormone receptor structure-function relationships. Physiological Reviews 82 473-502. (doi:10.1152/physrev.00031.2001)
52. Tahara K, Ban T, Minegishi T & Kohn LD 1991 Immunoglobulins from Graves' disease patients interact with different sites on TSH receptor/LH-CG receptor chimeras than either TSH or immunoglobulins from idiopathic myxedema patients. Biochemical and Biophysical Research Communications 179 70-77. (doi:10.1016/0006-291X(91)91335-A)
53. Tahara K, Ishikawa N, Yamamoto K, Hirai A, Ito K, Tamura Y, Yoshida S, Saito Y&KohnLD1997Epitopes for thyroid stimulating and blocking autoantibodieson the extracellular domain of the human thyrotropin receptor. Thyroid 7 867-877. (doi:10.1089/thy.1997.7.867)
54. Vlaeminck-Guillem V, Ho SC, Rodien P, Vassart G & Costagliola S 2002 Activationof the cAMPpathway by theTSHreceptor involves switching of the ectodomain from a tethered inverse agonist to an agonist. Molecular Endocrinology 16 736-746. (doi:10.1210/me.16.4.736)
55. Zeng H, Phang T, Song YS, Ji I & Ji TH 2001 The role of the hinge region of the luteinizing hormone receptor in hormone interaction and signal generation. Journal of Biological Chemistry 276 3451-3458. (doi:10.1074/jbc.M007488200)